Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to comment on: Bosi et al. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 2013;36:2887-2894.
Bosi E, Scavini M, Ceriello A, Cucinotta D, Tiengo A, Marino R, Bonizzoni E, Giorgino F; PRISMA Study Group. Bosi E, et al. Diabetes Care. 2013 Dec;36(12):e218. doi: 10.2337/dc13-1683. Diabetes Care. 2013. PMID: 24265387 Free PMC article. No abstract available.
Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C, Giordano C, Locatelli M, Bosi E, Bottazzo GF, Buzzetti R, Cucinotta D, Galluzzo A, Falorni A, Dotta F. Tiberti C, et al. Among authors: bosi e. Diabetes. 2008 May;57(5):1276-83. doi: 10.2337/db07-0874. Epub 2008 Mar 10. Diabetes. 2008. PMID: 18332100 Free article.
Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.
Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S, Songini M, Bonicchio S, Giorgino F, Bonifacio E, Bosi E, Buzzetti R; Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group. Lampasona V, et al. Among authors: bosi e. Diabetes Care. 2010 Jan;33(1):104-8. doi: 10.2337/dc08-2305. Epub 2009 Oct 6. Diabetes Care. 2010. PMID: 19808923 Free PMC article.
Effects of carbohydrate counting on glucose control and quality of life over 24 weeks in adult patients with type 1 diabetes on continuous subcutaneous insulin infusion: a randomized, prospective clinical trial (GIOCAR).
Laurenzi A, Bolla AM, Panigoni G, Doria V, Uccellatore A, Peretti E, Saibene A, Galimberti G, Bosi E, Scavini M. Laurenzi A, et al. Among authors: bosi e. Diabetes Care. 2011 Apr;34(4):823-7. doi: 10.2337/dc10-1490. Epub 2011 Mar 4. Diabetes Care. 2011. PMID: 21378215 Free PMC article. Clinical Trial.
Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR study: similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfaction.
Nicolucci A, Del Prato S, Vespasiani G; ELEONOR Study Group. Nicolucci A, et al. Diabetes Care. 2011 Dec;34(12):2524-6. doi: 10.2337/dc11-0900. Epub 2011 Sep 27. Diabetes Care. 2011. PMID: 21953799 Free PMC article. Clinical Trial.
Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention.
Scavini M, Bosi E, Ceriello A, Giorgino F, Porta M, Tiengo A, Vespasiani G, Bottalico D, Marino R, Parkin C, Bonizzoni E, Cucinotta D. Scavini M, et al. Among authors: bosi e. Acta Diabetol. 2013 Oct;50(5):663-72. doi: 10.1007/s00592-011-0357-y. Epub 2011 Dec 22. Acta Diabetol. 2013. PMID: 22189755 Free PMC article. Clinical Trial.
323 results